Analysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma

British Journal of Haematology

Volumn 154, Issue 3, 2011, Pages 413-415

  Saarinen, Silva ^a   Vahteristo, Pia ^a   Launonen, Virpi ^a   Franssila, Kaarle ^b   Kivirikko, Sirpa ^b   Lehtonen, Rainer ^a   Bain, Barbara J ^c   Bauduer, Frédéric ^d   Ünal, Ali ^e   Aaltonen, Lauri A ^a   Aittomäki, Kristiina ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c ST MARY S HOSPITAL   (United Kingdom)

^d CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^e Department of Medicine   (Turkey)

Author keywords

Cancer predisposition; Familial cancer; Hodgkin lymphoma; KLHDC8B; Nodular lymphocyte predominant Hodgkin lymphoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

5' UNTRANSLATED REGION; CANCER REGRESSION; CANCER RELAPSE; CHROMOSOME 2; CHROMOSOME 3; CLASSICAL HODGKIN LYMPHOMA; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEVER; GENE EXPRESSION PROFILING; GENETIC COUNSELING; HEREDITY; HISTIOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KLHDC8B GENE; LETTER; LYMPHADENOPATHY; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PANCYTOPENIA; PHENOTYPE; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; REED STERNBERG CELL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

ADOLESCENT; ADULT; AGED; CELL CYCLE PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 79960271334     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08528.x     Document Type: Letter

References (9)

1. Bauduer, F., Vassallo, J., Delsol, G. & Brousset, P. (2005) Clustering and anticipation for nodular lymphocyte predominance Hodgkin lymphoma within a French Basque kindred. British Journal of Haematology, 130, 648-649.
2. Brune, V., Tiacci, E., Pfeil, I., Doring, C., Eckerle, S., van Noesel, C.J., Klapper, W., Falini, B., von Heydebreck, A., Metzler, D., Brauninger, A., Hansmann, M.L. & Kuppers, R. (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. The Journal of Experimental Medicine, 205, 2251-2268.
3. Campbell, G.N., Lloyd, J., Wotherspoon, A., Coulter, C. & Bain, B.J. (2004) Nodular lymphocyte predominant Hodgkin lymphoma in siblings. Leukemia & Lymphoma, 45, 609-611.
4. Kerzin-Storrar, L., Faed, M.J., MacGillivray, J.B. & Smith, P.G. (1983) Incidence of familial Hodgkin's disease. British Journal of Cancer, 47, 707-712.
5. Kuppers, R. (2009) The biology of Hodgkin's lymphoma. Nature Reviews. Cancer, 9, 15-27.
6. Poppema, S., Delsol, G., Pileri, S.A., Stein, H., Swerdlow, S.H., Warnke, R.A. & Jaffe, E.S. (2008) Nodular lymphocyte predominant Hodgkin lymphoma. In: WHO Classification of Tumours of the Haemotopoietic and Lymphoid Tissues (eds S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, V. Thiele & J.W. Vardiman), pp. 323-325. IARC Press, Lyon.
7. Salipante, S.J., Mealiffe, M.E., Wechsler, J., Krem, M.M., Liu, Y., Namkoong, S., Bhagat, G., Kirchhoff, T., Offit, K., Lynch, H., Wiernik, P.H., Roshal, M., McMaster, M.L., Tucker, M., Fromm, J.R., Goldin, L.R. & Horwitz, M.S. (2009) Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proceedings of the National Academy of Sciences of the United States of America, 106, 14920-14925.
8. Unal, A., Sari, I., Deniz, K., Ozkan, M., Kontas, O., Eser, B. & Cetin, M. (2005) Familial nodular lymphocyte predominant Hodgkin lymphoma: successful treatment with CHOP plus rituximab. Leukemia & Lymphoma, 46, 1613-1617.
9. Yung, L. & Linch, D. (2003) Hodgkin's lymphoma. Lancet, 361, 943-951.